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Transport ATPases make up a family comprised of six types of transporters responsible for 
moving molecules including but not limited to H+, Na+, K+, Ca2+, Mn2+, Cu2+ and even flipping 
phospholipids across membrane leaflets. These versatile pumps play a major role in setting the 
cell’s electrochemical gradient and many members arose during gene duplications from 
evolutionarily related isoforms. In this study we looked at the role of secretory pathway Ca2+/Mn2+-
ATPases in colon cancer biology. Two isoforms exist in mammalian cells however mounting 
evidence suggests that they may not play a compensatory role. To determine if there is a distinct 
contribution of SPCA1 or SPCA2 to colon cancer growth we performed a simple growth assay. 
We found that both shSPCA1 and shSPCA2 reduced Caco-2 growth at day three due to elevations 
in apoptosis.  
In the second part of this study, the contribution of two isoforms of the proton pump, V-
ATPase a, were examined in the context of Candida albicans infection. C. albicans thrives in the 
gut as a commensal but maintains the propensity to establish septicemia and may become fatal. 
We found that the vacuolar form of a (Vph1) was responsible for vacuolar acidification and zinc 
clearance. Vph1 mutation, but not secretory Stv1, diminished hyphae formation and failed to 
establish a systemic infection in mouse. We conclude that vacuolar acidification is critical in the 
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INTESTIINAL BIOLOGY – A BRIEF OVERVIEW 
Epithelia are responsible for establishing and maintaining a critical barrier for the 
host, separating self from the environment. Inherently, this cell layer must permit transport 
of nutrients and waste while barricading toxins and pathogens. The intestinal epithelial cell 
is a remarkable example of this function, separating the host from around one billion 
microbes per milliliter of luminal material all while facilitating rapid and efficient 
absorption of dietary nutrients. These cells develop a polarized cell morphology with 
distinct apical and basolateral membrane surfaces expressing designated transporters for 
water absorption, ion homeostasis, glucose transport and much more.  
Under certain conditions the human intestine may lose up to one-hundred billion 
cells per day, and adult stem cells must replenish lost intestinal epithelial cells at an 
astounding rate. In addition to the growing list of intestinal stem cell populations, the 
gastrointestinal epithelia is comprised largely of absorptive cells (Na+ absorptive and Cl- 
secretory), as well as highly secretory cells including Paneth cells, enteroendocrine cells 
and goblet cells. In all models of intestinal stem cell biology, replicative cells are retained 
within the intestinal crypt and nonreplicative cells migrate up the crypt-villus axis toward 
the intestinal lumen.  
Cancers of the intestinal epithelium are common with high prevalence in 
westernized countries. Over 100,000 individuals were newly diagnosed with colon cancer 
in the United States during 2013, and over 50,000 deaths from colorectal cancers are 
predicted for the year 2014 (NCI). A great number of lethal cancers have been prevented 
by routine colonoscopy. In current medical practice, all cancerous and precancerous lesions 
discovered must be completely removed for pathological examination. Upon histological 
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assessment the tumor grade, and hence prognosis, can be defined (Hassan et al. 2011, 
Winawer et al. 1993). 
Colorectal cancer is said to begin first as a benign adenoma in the form of a polyp. 
This finger-like projection is ultimately caused by mutations leading to dysplasia 
(developmental anomaly). A fraction of these adenomas will acquire mutations allowing a 
subset of cells to progress toward stages of carcinoma. Alternatively, some colorectal 
cancers are said to develop de novo and may be associated with growths that have high 
microsatellite instability (Hassan et al. 2011). 
In the 1980’s it was first recognized that colon cancers arise from a single mutated 
clonal stem cell. Typically these epithelial stem cells must carry mutations in four or five 
oncogenes or tumor suppressors in order to establish a carcinoma (Ponder and Wilkinson, 
1986, Fearon and Vogelstein, 1990). For example, approximately 50% of large adenomas 
and carcinomas carry a mutation in kras. Allelic loss of tumor suppressor p53 occurs in 
75% of colon carcinomas and loss of heterozygosity of DCC in 70% of carcinomas (Fearon 
and Vogelstein, 1990). In theory these mutations are acquired randomly and are selected 
for a growth advantage over time, behaving in a cumulative manner. Figure 1 summarizes 
current knowledge of mutations associated with colorectal cancer and stage. 
In the mouse small intestine alone, three-hundred million cells are replaced daily to 
compensate for cell loss at villus tips, however, nearly all digestive cancers arise in the 
colon (Barker 2014). Factors that may contribute to the fifty-fold higher incidence of colon 




Figure 1: Common mutations in colorectal cancer appear in red text. 
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colon epithelium as well as a higher presence of bacteria and longer contact with stool, 
which may cause stress (Neugut et al. 2001). It has also been observed that apoptosis is 
activated in the crypt base of the small intestine but not the colon, another potential means 
for mutation retention in the colon epithelium (Grossmann et al., 2002). As epithelial cells 
reach the villus or luminal surface they undergo apoptosis and subsequent shedding. 
Electron micrographs reveal the formation of apoptotic bodies following nuclear 
condensation, with apoptosis late in the crypt-villus axis when sample preparation is 
delayed (Hall et al. 1994). In contrast, detection of cleaved caspase-3 (a protease activated 
in early apoptosis) shows increasing staining at villus or luminal planes (Grossmann et al., 
2002). In rare instances a cell may resist the normal sequence of events and give rise to a 
malignant lesion.  
Conditions increasing one’s risk of either small bowel or colon cancer includes FAP 
(familial adenomatous polyposis a hereditary mutation in APC leading to dysregulated β-
catenin) HNPCC (Hereditary Nonpolyposis Colorectal Cancer a familial mutation in DNA 
mismatch repair) or Crohn’s disease and ulcerative colitis due to chronic inflammation 
(Neugut et al. 2001). However, the vast majority of patients (75%) have no hereditary 
linkage to the disease. There are, however, environmental factors that may increase one’s 
likelihood of developing colorectal cancer, such as smoking, consuming a westernized diet 
and lack of exercise. Preventative treatments are presently being explored and include 





Dietary calcium with vitamin D3 supplementation has been shown to reduce the 
incidence of cancer in a four-year randomized study (Lappe et al. 2007). Under dietary 
calcium restriction, renal vitamin D is synthesized and acts on enterocytes to increase 
calcium absorption by generating calcium transporters TRPV6, PMCA1, and NCX1 as 
well as calbindin D and alkaline phosphatase. Interesting, though, duodenum from mice 
lacking both TRPV6 and calbindin D 9k can still induce calcium absorption in response to 
vitamin D3, albeit about half WT (reviewed in Centeno et al. 2009, Benn et al. 2008) 
Additionally, calcium uptake induced during pregnancy can occur in the absence of the 
vitamin D receptor in mice (Fudge and Kovacs 2010). How calcium absorption is induced 
under these circumstances is not understood. 
Calcium is a ubiquitous ion present in all of our cells at a low level, and is reserved 
for the transmission of several specific cues. A series of calcium-ATPases, exchangers, 
channels and buffers are responsible for keeping cytosolic calcium levels around 100nM. 
During calcium signaling, cytosolic free calcium levels rise and trigger a number of 
kinases, phosphatases and transcription factors which will be the focus of this chapter. 
Before entering the cell, calcium from the extracellular space can trigger signaling 
through the calcium receptor, CaSR. This G-protein coupled receptor is activated by 
calcium from the cell surface and produces indirectly (through phospholipase C β) IP3 and 
DAG. IP3 signaling is a recurrent theme utilized in the release of calcium from intracellular 
stores. Both the ER and the Golgi express the IP3 receptor, a calcium channel which 
releases the luminal calcium upon stimulation. Therefore, IP3 production results in an 
increase in cytosolic calcium which can act on several downstream components. In 
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combination with DAG, Ca2+ activates PKC to inhibit CaSR and promote differentiation 
(reviewed in Lamprecht and Lipkin 2003). 
  One way in which PKC promotes differentiation is via blocked cyclin D1 and 
enhanced levels of the cyclin dependent kinase inhibitors, WAF1 and KIP1. These factors 
act in concert to facilitate cell cycle exit and differentiation. Additionally, CaSR signaling 
through PKC and phosphotyrosine kinase (PTK) stimulated MAPK and subsequent 
ERK1/2 signaling in an overexpression model (Kifor et al. 2001, Lamprecht and Lipkin 
2003).  
Components of the APC signaling pathway have also been influenced in the 
presence of extracellular calcium lending toward a tumor suppressing scenario. β-catenin 
activity is reduced and E-cadherin levels are elevated. In the unstimulated cell, β-catenin 
is bound to APC and destined for phosphorylation and ubiquitinylation via GSK and 
ubiquitin ligases, respectively. Additional β-catenin is sequestered to the cell cortex by E-
cadherin. However, upon Wnt signaling (or APC mutation as is frequently seen in colon 
cancers, Fig. 1), the destruction complex is disassembled and β-catenin can enter the 
nucleus. Downstream transcription factors belonging to the TCF-family activate cyclin D1, 
c-MYC and Survivin to promote oncogenesis (Lamprecht and Lipkin 2003). 
Interestingly, cancers that are dedifferentiated do not respond to extracellular 
calcium. This has been correlated with a loss of CaSR expression, thus emphasizing the 
importance of this receptor. However, extracellular calcium can inactivate bile acids and 
ionized fatty acids consequently eliminating them from potentially damaging enterocytes 
(reviewed in Brennan et al. 2013). For these reasons, dietary calcium supplementation may 
decrease incidence of colorectal cancers.  
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IP3 may be synthesized in response to a number of signals including increases in 
cytosolic Ca2+, GPCRs and RTKs. In addition to IP3, three other calcium mobilizing 
messengers have been identified (Berridge et al. 2003). NAADP acts on the recently 
identified two pore channel, which is expressed ubiquitously and localizes to acidic 
vesicles. cADPR opens the RYR (ryanodine receptor) and isoform 1 (RyR1) has been 
found to be expressed in enterocytes (Prinz and Diener 2008). And finally, sphingosine-1-
phosphate can act as a second messenger acting on intracellular receptors or as a secreted 
ligand binding to GPCRs (Takabe et al. 2008).  
After calcium stores have been released they must be replenished. The ER triggers 
calcium entry in a store-operated manner via the calcium sensor, STIM1. STIM1 is a 
transmembrane protein that binds Ca2+ in the ER lumen. When calcium levels are low, 
STIM1 oligomerizes and forms punctate clusters on the ER membrane. These membranes 
can place STIM1 in juxtaposition with the calcium channel Orai1 and initiate calcium entry 
from the extracellular space. Recently, our lab found that Orai1 can also be opened by a 
Golgi-resident protein (SPCA2) in a store-independent manner. The mechanism behind 




SECRETORY PATHWAY CALCIUM-ATPASES (SPCAS) 
In this study I examined the role of the secretory pathway in colon cancer biology 
via the calcium/manganese transporter family, SPCA (Secretory Pathway 
Calcium/Manganese-ATPases). Two isoforms (SPCA1 and SPCA2) exist in tetrapods and 
belong to the family of P-type ATPases (Pestov et al. 2012). SPCAs have homology to 
other Ca2+-ATPases (SERCA, PMCA) with a conserved A, N and P (actuator, nucleotide-
binding and phosphorylation) domain structure. Transporters belonging to the P-Type 
Ca2+-ATPase family have a conserved 10 transmembrane helices with loops containing 
SERCA-like T-G-E and D-P-P-R motifs (Van Baelen et al. 2004). An EF hand motif in the 
N-terminus can bind calcium and modulate the enzyme’s calcium affinity (Wei et al. 1999). 
SPCAs have less reactivity to thapsigargin (SERCA inhibitor) or vanadate/lanthanum 
(PMCA inhibitors) so in order to study these pumps we use primarily genetic approaches 
(Ton et al. 2002). 
SERCA structure and function has been studied extensively and is frequently used 
as a basis for understanding SPCAs. Like SERCA, SPCAs complete a reversible catalytic 
cycle. In the first half of the enzymatic cycle, the calcium binding site of SERCA faces the 
cytosol. Upon binding of two calcium ions, the enzyme is primed for phosphorylation 
transfer from ATP to a conserved aspartic acid. Next the phospho-enzyme may switch 
accessibility with the calcium-containing pore now facing the vesicle lumen. Calcium ions 
exit the low affinity Ca2+-binding site. Subsequently, the phosphate is hydrolyzed and the 
enzyme can return to its original state (de Meis and Vianna 1979, Dode et al. 2002). A key 
aspartic acid is the site for the phosphorylation reaction and, if mutagenized, results in an 
inactive pump. Unlike SERCA, SPCAs have specificity for both calcium and manganese 
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ions and transport through one, not two, pores as site I has been mutagenized (Van Baelen 
et al. 2004). Thus, mutation of a conserved glutamine residue (Q783;PMR1) in the pore of 
SPCAs creates a pump with intact specificity for Mn2+ but loss of a Ca2+ binding site (Wei 
et al., 2000). The SPCA1 gene has 4 transcript variants (a-d) with SPCA1a, b, and d all 
having a Km for Ca2+ around 0.2µM. SPCA1c is missing the tenth transmembrane domain 
and is functionally inactive (Van Baelen et al. 2004). The substrate concentration at half 
saturation for Ca2+ transport mediated by human SPCA2 hovers around 0.25µM.  
Although their transport characteristics are similar, SPCA1 and SPCA2 differ in 
their expression profile. With a northern dot blot, the Wuytack laboratory arrayed human 
tissue RNAs for both SPCA1 and SPCA2. SPCA1 is expressed ubiquitously in human 
tissue samples while SPCA2 has a restricted expression pattern with high expression in 
secretory tissues. Among samples highly expressing SPCA2 were fetal and adult lung, 
thyroid, salivary and mammary glands, placenta, bladder, prostate, testis, trachea and high 
expression was observed throughout the digestive tract from the stomach to the rectum 
(Vanoevelan et al. 2005). Similar findings were reported in rat tissue samples by RT-PCR, 
with increased variability of SPCA1 transcript across tissue samples (Pestov et al. 2012).  
Immunolocalization results are mixed and depend upon the cell type analyzed and 
the antibody used. Vanoevelan et al. found SPCA1 and 2 localizes with the Golgi marker 
TGN46 in human colonic epithelial cells, in accord with localization studies of the yeast 
orthologue PMR1. However, in WIF-B polarizing liver cells SPCA1 localizes not only to 
the trans-Golgi (TGN38) but to post-Golgi vesicles adjacent to the basolateral membranes 
(Leitch et al. 2011). Immunohistochemistry in the rat duodenum suggests that SPCA2 
localizes to the plasma membrane in these cells, unlike the perinuclear organization of 
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GFP-tagged SPCA2 in HT-29 cells. However, this study has shortcomings; (1) the lack of 
a colabel for compartment designation and (2) the absence of a biochemical study to 
confirm exposure on the plasma membrane (Pestov et al. 2012). SPCA2 is present in rat 
hippocampal neurons and has a punctate vesicular distribution partially overlapping with 
the Golgi (Xiang et al. 2005). 
In humans, the role of SPCA1 has been more comprehensively studied than that of 
SPCA2. Literature on SPCA1 primarily focuses on Hailey-Hailey disease, a skin disorder 
that results from haploinsufficiency of SPCA1 due to a dominant autosomal mutation. Not 
only did keratinocytes from patients have higher resting calcium, but calcium levels 
remained elevated compared to healthy keratinocytes under conditions of increased 
extracellular calcium (Hu et al., 2000). Although Golgi and ER structure were 
morphologically aberrant in the SPCA1 knockout mouse (Okunade et al., 2007), human 
haploid keratinocytes had normal ER calcium (Hu et al., 2000). Decreased calcium in 
intracellular stores has been observed by Fura-2 imaging during ionomycin-mediated 
release in human keratinocytes (Hu et al., 2000). 
In the SPCA1 knockout-derived embryonic neural tube cells, Okunade et al. found 
significant changes in Golgi and ER ultrastructure including dilation of both Golgi and ER, 
increasing disorganization of the organelles and a higher number of Golgi bodies and 
Golgi-associated vesicles. They also recorded an increase in apoptotic index but not mitotic 
index, which is the likely cause of death at embryonic day 11. Also observed was an 
increase in the number of lipid droplets and dense granules in the cytoplasm of SPCA1 null 
embryos. Interestingly, SPCA1 heterozygous mice did not develop Hailey-Hailey disease 
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with age but instead some mice developed squamous cell tumors of the skin and esophagus 
(Okunade et al. 2007).  
Despite these aberrations, ultrastructural examination of tight junctions, 
desmosomes and basolateral membrane seemed normal, suggesting that sorting 
mechanisms may be intact (Okunade et al. 2007). More recently the role of SPCA1 in HeLa 
cells has been examined by shRNA in the context of trafficking rates.  In accord with 
findings in the knockout mouse, SPCA1 siRNA disrupts the Golgi apparatus into 
disorganized vesicles and caused elevated cell death. A temperature sensitive version of 
VSVG was tracked in SPCA1 knockdown cells. VSVG exits from the ER to the Golgi 
while enroute to the plasma membrane. In SPCA1 knockdown cells, VSVG was stuck in 
the Golgi. Intra-Golgi and plasma membrane trafficking of VSVG was also impaired 
(Micaroni et al. 2010). 
SPCA2 is believed to have evolved from SPCA1 during a gene duplication event 
some time during tetrapod evolution as it is present in amphibians, reptiles, birds, platypus 
and mammals (Pestov et al. 2012). In 2010 Feng et al. showed that SPCA2 (secretory-P-
type ATPase 2) is involved in breast cancer aggressiveness through increasing cell cycle 
progression via elevations in cytosolic calcium. Unexpectedly, catalytically inactive 
SPCA2 also modulated cytosolic calcium to the same extent as wildtype. This phenomenon 
is regulated by SPCA2-triggered opening of the CRAC channel, Orai1 (Feng et al. 2010). 
This mechanism may actually arise from SPCA2’s ability to traffic Orai1 (Cross et al. 
2013). In contrast to other studies in SPCA1 deficient cells, only suppression of SPCA2 in 
MCF-7 cells caused a growth defect and a decrease in basal calcium in the cytoplasm. 
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Interestingly, gene profiling comparing healthy colon tissue versus cancer failed to 
detect elevations in SPCA2 but elevation of SPCA1 was found in several publications (Fig. 
2a,b). Colon cancers often have genome instability with loss or duplication of alleles, a 
possible explanation for the data showing both overexpression and repression of SPCA 
transcripts. How may SPCA1 be upregulated in colon cancers? In a recent article published 
by Micaroni and Malquori, 2013, the ASTE1 (Asteroid1, implicated in DNA repair) gene 
and SPCA1 gene overlap in the human genome. SPCA1 shares its 3’UTR in sense and may 
be coregulatory. As they reviewed, some 80% of colorectal cancers are mutated in ASTE1 
and may regulate isoform expression of SPCA1. Because isoform a and b-d have very 
different 3’ UTRs they may be regulated by distinct miRNAs.   
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SPCA1 AND 2 IN COLON CANCER BIOLOGY 
RESULTS 
Although SPCA2 has been implicated in breast cancer aggressiveness, gene 
profiling data show that SPCA1 is overexpressed in colon cancers (Fig. 2a). We designed 
several assays to look at the role of SPCAs in colon cancer growth using the differentiating 
cell line Caco-2, which was derived from an adenocarcinoma and expresses many of the 
transporters present in the intestinal epithelium (Sun et al. 20002). As these cells become 
confluent they undergo programmed differentiation and form polarized monolayers that 
develop a transepithelial electrical resistance (TER) associated with tight junction 
formation. In pharmaceutical research the cell line is used for transport studies to model 
drug delivery in vivo. We used Caco-2 as a model for colon cancer and assayed for an overt 
growth phenotype in SPCA1 or SPCA2 knockdown. 
SPCA1 and SPCA2 are detectable in human duodenum undifferentiated organoid 
cells by RT-PCR (Fig. 3). Additionally, HA-tagged SPCAs localize to the Golgi of Caco-
2 cells similar to staining described in Vanoevelan et al. 2005 (Fig. 4). To understand the 
role of these transport ATPases in colorectal cancer we used a lentiviral delivery system to 
knockdown SPCA1 and SPCA2 individually.   
 In order to observe the growth of colon cancer cell lines over time we assayed for 
cellular NADH/NADPH with the Promega CellTiter 96 Aqueous One Solution Cell 
Proliferation Assay kit. The colorimetric dye, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyhenyl)-2-(4-sulfophenyl)-2H-tetrazolium), with electron coupling agent 
PES (phenazine ethosulfate) undergoes a redox reaction and produces a formazan 




compound is reduced by NADPH or NADH via cellular dehydrogenases. The change in 
Caco-2 cell number observed in shSPCA1 was similar to shSPCA2 and reached greater 
than 25% reduction by day 3. A similar growth defect has been reported in WIF-B cells for 
SPCA1 knockdown (Leitch et al. 2011). Additionally HCT116 had a 50% reduction in 
growth upon SPCA2 knockdown, but not for SPCA1. DLD1 had a reduction reaching 
about 30% on cell growth day 4 for only one of two hairpins tested. We next sought to 
identify the mechanism behind the growth changes observed due to knockdown, and 
predicted four possible causes comprising the proliferative, apoptotic or necrotic pathways 
or a delay in the cell cycle. We can find evidence for SPCAs being involved in each of 
these pathways/cellular processes. 
  
Figure 2a: Hits for overexpression of SPCAs in colon cancer as compared to healthy tissue (Oncomine). Each box 
represents a publication with pink-red shading indicating relative (fold or significance). Gray boxes indicate missing 
data. 
Figure 2b: Hits for repression of SPCAs in colon cancer as compared to healthy tissue (Oncomine) 
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Figure 4: HA-SPCA1 (A) and HA-SPCA2 (B) (green) colocalize with Golgi marker Golgin97 (red) in transiently 










































































Human Duodenum Intestinal Epithelial Cells 
Organoid- Undifferentiated 
Ct:   28.9    32.3    N/A     N/A 
Figure 3: Product from quantitative RT-PCR reaction detecting SPCA1 and SPCA2 in human duodenum cDNA grown as 





 Figure 6: Comparing growth defects in various colon cancer cell lines in the presence or absence of SPCA hairpin. Error 
bars represent standard deviations of three biological experiments. Results from two individual hairpins were averaged 

































































































































   
Figure 7: Proliferative index quantification in Caco-2 shows no statistically significant difference in proliferation in 
shSPCA treatment. Error bars represent standard deviations of three biological replicates. Immunostaining for Ki67 in 
control Caco-2 cells three days after seeding (right). Green staining marks Ki67 positive cells and DAPI was used to stain 
all cells as a control. 
We assayed for cell cycle progression using antibody against Ki67, a protein that 
is associated with rRNA production and is expressed in all phases of the cell cycle. Its 
absence from G0 cells makes it suitable to quantitate the percentage of proliferating cells, 
also known as the proliferation index. In node-negative breast cancers Ki67 is also 
correlative with prognosis and sensitivity to chemotherapy (Urruticoechaea et al. 2005). 
Several thousand Caco-2 cells were examined at a time to calculate the percentage of cells 
expressing Ki67 (about 4%) and we failed to detect a statistically significant decline in 
proliferative index upon knockdown of SPCA. These results imply that the growth defect 
observed was not due to an impairment in cell cycle entry. One criticism of this assay is 
that only a small proportion of cells labeled positively for Ki67 and the actual proliferative 
pool is expected to be larger because the doubling time for this cell line is about twenty-
four hours. In one report the proliferative index of primary colorectal cancers ranged from 




























We looked at apoptosis by measuring cleaved caspase-3. In Caco-2 cells the 
mitochondrial destruction pathway is intact and can activate caspases. Staurosporine is a 
compound isolated from Streptomyces staurosporesa and is an inhibitor of numerous 
kinases in the cell making it a suitable positive control for apoptosis. In the nanomolar 
range, staurosporine inhibits CaMK-11, MLCK, PKA, PKC, and PKG and in the 
submicromolar range (0.2uM – 1uM) it induces apoptosis. I used staurosporine at a 
concentration of 2uM for 8 hrs as previously reported (Chakrabarti et al. 2003). After 
finding that cleaved caspase-3 was still not detectable, I treated Caco-2’s with 10uM 
staurosporine for 24hrs (Lavaggi et al., 2011), these conditions were used for a DNA 
fragmentation assay which is a late event in apoptosis. At the time of protein harvest cells 
were visibly rounded but not detached from the cell culture surface. Cleaved caspase 3 was 
still undetectable. 
An increase in the permeability of membranes of apoptotic cells can be detected by 
uptake of the selective dye YO-PRO-1. Flow cytometry of staurosporine treated Caco-2 
cells revealed an increase in the uptake of YO-PRO-1 but not propidium iodide which 
stains dead cells. There was approximately a 50% increase in the percentage of cells that 





Figure 8: YO-PRO-1 staining was used to quantify the percentage of Caco-2 cells that were apoptotic upon treatment 
with shRNA against SPCA1 or SPCA2. 
The proportion of necrotic cells was determined via assay for released LDH (lactate 
dehydrogenase) in cell culture supernatants. During necrosis and late in apoptosis the cell 
membrane loses its integrity and can leak cytoplasmic contents. Cytosolic LDH is released 
into the cell culture medium and can catalyze the conversion of supplemented lactate to 
pyruvate by utilizing NAD+ as an electron acceptor. The NADH product is next oxidized 
during the formation of a colored formazan product. This simple colorimetric assay 
revealed that only less than 1:10,000 cells were necrotic and treatment with shSPCA1 or 

























It is plausible that SPCA 
knockdown cells take longer to 
progress through the cell cycle. 
Calcium oscillations trigger 
transitions throughout the cell cycle. 
It is possible that SPCAs help to 
regulate this type of calcium 
increase. To address this, we first 
performed cell cycle profile analysis 
using propidium iodide to stain DNA. No significant change in cell cycle profile was 
observed upon treatment of shRNAs. 
 
Figure 10: Cell cycle analysis by flow cytometry of fixed Caco-2 stained with propidium iodide to quantitate DNA 
amount. 
MATERIALS AND METHODS: 
Cell culture: Caco-2 bbe1 were kindly donated from the Mooseker lab (Sarker et al. 2011). 




































Figure 9: Necrosis of Caco-2 lentivirally knockdown for SPCA1 or 




supplemented with 15mM HEPES pH 7.4 and 10% FBS. For lentiviral transduction, Caco-
2’s were selected under 10ug/ml puromycin for 3-7 days. Cells were deemed positive for 
infection if they persisted when untransduced control cells had died. Sequences used for 
lentivirus include (Feng et al 2010): 
pLKO.1 mission (shscrm): CAACAAGATGAAGAGCACCAA 
pLKO.1 509 (shSPCA1[1]): TACTTATCGTTGTTACAGTTG 
pLKO.1 1016 (shSPCA1[2]): TCATCATGTTGGTTGGCTGG 
pLKO.1 386 (shSPCA2[1]): GCGAACCTGTGTGGAAGAAAT 
pLKO.1 1040 (shSPCA2[2]): GGAAACAACTCCTGAGTAT 
Cell Growth Assay: Cell growth was monitored by the CellOne Proliferation Assay Kit 
(Promega). Briefly, 5e3 cells were seeded per well into a 96-well plate. Readings were 
taken at time 0 and consecutively every 24hrs. Cell culture media was also changed on a 
24 hr basis leading up to the read date. 
Cell Proliferation: Caco-2 selected for knock down were seeded at a concentration of 1e5 
cells/ml onto collagen coated coverslips. Media was changed every day and on the third 
day cells were fixed and processed for immunofluorescent staining as previously published 
(Araki et al. 2003). Rabbit polyclonal antibody against human Ki67 was purchased from 
Santa Cruz Biotechnology (sc-15402). To determine the proliferative index, the number of 
Ki67 positive cells were divided by the total number of nuclei per field. Error bars represent 
standard deviations of the mean of three experiments. 
LDH Release Assay: To assay for necrosis, cellular supernatants were collected 20 hrs 
after the last media change. LDH in the supernatant was normalized to total cellular LDH 
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and is presented as % cell death as described by the manufacturer. Samples were processed 
with the Cytotox 96 Assay (Promega). 
Cell Cycle Analysis: Performed using propidium iodide as previously described (Riccardi 
and Nicoletti 2006). Briefly, Caco-2 were washed twice with HBSS, all floating cells were 
collected. Trypsinized cells were harvested and the reaction was stopped with addition of 
5X volume of growth medium. Pelleted cells were resuspended in PBS for counting and 
diluting to 1e6/ml. 1 ml of cells were pelleted again and resuspended in 500ul for fixation 
in 4.5ml 70% ice cold ethanol. Cells were gently vortexed wile ethanol was added slowly. 
Fixed cells were stored at -20°C overnight before washing in PBS. Finally cells were 
stained in 1ml of propidium iodide staining solution (40ug propidium iodide, 50mg RNase 
A) for 30-60 minutes prior to analysis. 
Apoptosis: 
Caco-2 were harvested from the tissue culture medium and plate by trypsinization. Trypsin 
was inactivated with cell culture medium and pelleted cells were washed with 5ml PBS. In 
1ml PBS, 1e6 cells were resuspended and 1ul each of YO-PRO-1 and propidium iodide 
from staining kit (Molecular Probes V13243) were added. Keep cells on ice before analysis 
by flow cytometry. 
EdU Uptake: 
To adherent cells, 20uM EdU solution was applied and cells were returned to the incubator 
for a 20 minute pulse. Caco-2’s were harvested by trypsinization and washed in PBS with 





Although there are multiple ways in which calcium regulates proliferation by cell 
cycle progression or cell cycle exit, prolonged elevations in calcium can lead to increased 
rates of cell death. Two overarching mechanisms of cell death are observed in vivo. First, 
apoptosis is the controlled programming of cell death in which cellular components are 
degraded or digested in a regulated fashion to optimize toxicity reduction. In the digestive 
tract epithelia are constantly replenished by the stem cell niche in the crypt; in order to 
counterbalance this growth apoptosis plays a major role in regulating the overall cell 
population, with the majority of apoptosis occurring toward the villus tip (Hall et al., 1994). 
Caspases are responsible for digesting intracellular proteins to prepare the cell for 
apoptosis, with upstream initiator caspases activating downstream effector caspases. Both 
intrinsic and extrinsic pathways serve to activate caspases (Reed 2000).  
Alternatively, a second mechanism in which cellular components are destroyed in 
a dysregulated manner is termed necrosis and is the primary mechanism of cell death due 
to physical trauma i.e. burns and oxidative damage (Galluzzi et al. 2012). In mouse 
embryos lacking SPCA1, increased apoptosis was observed in embryonic neural tube cells, 
making necrosis a less likely cause of the hairpin-induced growth defect.  
Reports of hyperoxia or DNA damage repair can delay S phase (Shenberger and 
Dixon, 1999; Cliby et al. 2002). As transport of Ca2+ and Mn2+ from the cytosol to the 
Golgi lumen is impaired in shSPCA strains, we might expect to detect an increase in levels 
of these ions in the cytoplasm. Manganese tends to have an antioxidant effect, complexing 
with small molecule metabolites to manage superoxide. In addition, Mn2+-requiring 
superoxide dismutase of the mitochondria converts superoxide to hydrogen peroxide and 
oxygen, which are far less toxic. Formation of the Mn2+-associated complexes seems to 
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require Pho80/Pho85p and Sch9p signaling and the downstream kinase, Rim15p, in yeast 
(Culotta and Daly, 2013). 
Despite this antioxidant-promoting scenario, affected keratinocytes from Hailey-
Hailey disease patients showed signs of ROS by dihydrorhodamine 123 assay (Cialfi et al. 
2009). Similarly, miR-125b, activated by ROS, contributed to Hailey-Hailey disease 
manifestation (Manca et al. 2011). Because these keratinocytes have been removed from 
the host, immune responses can no longer contribute to ROS experienced by the 
epithelium, implying that the source of the oxidant is cell autonomous. In Kluyveromyces 
lactis yeast, elevated ROS was also observed in ∆pmr1 strains and was associated with 
mitochondrial morphological aberrations (Uccelletti 2005). Finally, Golgi calcium 
signaling has been linked to mitochondrial calcium uptake in pancreatic acinar cells 
(Dolman and Tepikin, 2006; Dolman et al. 2005). 
Growth block has been reported in Micaroni et al. 2010 (HeLa) and Leitch et al. 
2011 (WIFB) as well as Okunade et al. 2007 (embryonic neural crest cells). By assessing 
the relative contribution of apoptosis or necrosis to shSPCA1 and shSPCA2 we conclude 
that the observed colorectal cancer cell growth defects are attributed to the apoptotic 
pathway. Attempts to detect cleaved caspase-3 failed. Cleaved caspase-3 is detectable upon 
treatment of Caco-2 cells with butyrate, proving that this signaling pathway is intact 
(Ruemmele et al. 2003). Perhaps we were unable to detect cleaved caspase-3 due to the 
small number of cells undergoing apoptosis on a given day (around 5%). 
There are variations on cell death which were not explored in this study. In oncosis, 
cells swell and lose plasma membrane integrity during preparation for cell death (Majno 
and Joris, 1995).  
25 
 
In sum, both SPCA1 and SPCA2 are involved in cell survival. Given that loss of 
SPCA1 elevates reactive oxygen species in human keratinocytes, one could speculate that 
the origin of the damaging ROS is the mitochondria via impaired Golgi or ER signaling. 
Okunade et al. showed that Golgi and ER structure are altered in the SPCA1 knockout 
mouse. Alternatively, the ER monoxygenases can synthesize ROS and ultimately lead to 
apoptosis (Circu and Aw, 2010).   
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COLON CANCER AND EPITHELIAL-MESENCHYMAL TRANSITIONS 
In colon cancers, the epithelial-mesenchymal differentiation axis was the first 
principal component and more mesenchymal-type expression profiles correlated with more 
advanced tumor stages (Loboda et al. 2011). Colorectal cancers are known to undergo 
epithelial-mesenchymal transitions during metastasis and subsequently redifferentiate at 
the metastatic site into epithelial cells again. This process is thought to be regulated by the 
tumor environment (Brabletz et al. 2005).  
In the Wnt signaling pathway, Wnts bind and activate the Frizzled receptor, thus 
inhibiting the action of GSK3β/APC/axin/conductin complex. Under unstimulated 
conditions, GSK3β phosphorylates β-catenin at the N-terminus and signals the subsequent 
degradation of β-catenin. Conversely, GSK3β inhibition liberates cytosolic β-catenin to 
interact with adherens junctions or translocate to the nucleus where it exerts its 
transcriptional activity at oncogene promoters. Additional environmental factors play a 
role in β-catenin localization and action include TGFβ, TNFα, TFF3, IGFI and II, EGF and 
HGF. β-catenin activation causes epithelial-mesenchymal transitions or can result in failure 
to differentiate into epithelia (reviewed in Brabletz et al. 2005). In this system E-cadherin 
is a major player in β-catenin regulation. 
We chose to look at what role SPCAs may be playing in Caco-2 transitioning from 
mesenchymal to epithelial cells. Trafficking studies in HeLa show defects in VSVG 
transport upon knockdown of the Ca2+/Mn2+ ATPase, SPCA1 (Micaroni et al. 2010). 
Additionally, the differentiation of WIF-B cells was delayed in SPCA1 knockdown (Leitch 
et al. 2011). Components belonging to intracellular calcium handling have been shown to 
change in colon cancer progression, e.g. the loss of SERCA3 (reviewed in Lamprecht and 
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Lipkin 2003). We hypothesized that knockdown of SPCAs would result in trafficking 
defects of E-cadherin, thus altering the differentiation status of the colorectal 
adenocarcinoma-derived cell line, Caco-2. 
Caco-2 cells induce expression of the epithelial marker protein E-cadherin in the 
differentiated state (data not shown), suggesting that a mesenchymal to epithelial transition 
may be taking place. One established measure of Caco-2 differentiation is the development 
of a transepithelial electrical resistance (TER). As Caco-2 mature, a tight junction forms 
and limits the paracellular permeability of ions across the cell monolayer. By applying a 
constant voltage across cells grown in cell culture inserts, a current can be recorded. TER 
values begin to taper around 12 days after seeding and continues to increase slightly up to 
day 21. We deemed day 14 cells as “differentiated” in accord with TER recordings and the 
literature. No delay in TER development in Caco-2 treated with shSPCA1 or shSPCA2 
was found (Fig. 11). Correspondingly, immunofluorescent staining revealed that the tight 
junction protein ZO-1 localized correctly in control and knockdown cells suggesting that 
there was no developmental delay in Caco-2 differentiation upon depletion of SPCAs (Fig. 
12).  
  
Figure 11: Transepithelial electrical resistance (TER) measurements in growing Caco-2 cells over time. As cells reach 
confluence they develop tight junctions and electrical resistance plateaus. No significant change in TER development 


























We next examined components that abide by apicobasolateral sorting pathways in 
polarized epithelia. E-cadherin sorting begins at the trans-Golgi network facilitated by the 
ARF-GEF, BIG2. A dileucine motif is essential for the basolateral sorting of E-cadherin 
and binds to an unknown adaptor. Vesicles carrying E-cadherin dock to Sec6/8 complexes 
on the lateral membranes (Bryant and Stow, 2004). Thus we performed immunostaining 
for the adherens junction protein, E-cadherin, which binds and sequesters β-catenin thus 
suppressing EMT. In HeLa, knockdown of SPCA1 resulted in missorting of the plasma 
membrane targeted VSVG (Micaroni et al. 2010). E-cadherin localized properly to the 
basolateral membranes in fully polarized monolayers, suggesting that steady state levels of 
E-cadherin were unaltered by shSPCA treatment. 
In the late eighties and early nineties lectin staining was examined for histological 
differences in normal and diseased colon biopsy. We looked at wheat-germ agglutinin 
staining to label broadly apically localized glycosylated proteins. WGA-TRITC staining 
labeled the mucosa of unpermeabilized Caco-2 monolayers and seemed to have 
approximately the same intensity and distribution of signal. Although glycosylation defects 
may exist, the steady-state pool of glycoconjugates at the apical membrane appear to be 
the equivalent. 
Phalloidin staining was performed to examine the morphology of the brush border. 
Phalloidin conjugated to FITC binds and labels filamentous actin in the cell, which is 
enriched for in the microvillus and around the cell cortex. Orthogonal sections were 
collected and random microvilli were selected for length calculation. The mean brush 




Figure 12: ZO-1 staining is intact in shscramble Caco-2 (left), shSPCA1 (center) and shSPCA2 (right) after 14 days of 
growth. 
 
Figure 13: E-Cadherin staining in Caco-2 grown for 14 days is not altered by shSPCA1 (center) or shSPCA2 (right). 
 
Figure 14: Phalloidin stains f-actin at the enterocyte brush border and cortical actin. On the left, a Z-stack of Caco-2 
transduced with shscramble (top), shSPCA1 (middle) and shSPCA2 (bottom) exhibit normal brush border morphology. 






Figure 15: WGA (wheat germ agluttinin)-red staining pre-permeabilization of polarized Caco-2 cells. The mucosa 













At this time, we noticed a trend toward decreasing cell size with shSPCA2 
treatment. Factors that may alter cell size and or growth rates include mTOR signaling. In 
Jurkat cells, prolonged inhibition of mTOR by rapamycin (inhibitor of mTORC1) had a 
reduced cell size and slowed growth, with more cells stuck in the G1 phase as revealed by 
flow cytometry of propidium stained cells at various time points. This G1 block could be 
reversed by the removal of mTOR 
inhibition (rapamycin) (Fumarola et al. 
2005). However mTOR inhibition by 
leucine starvation blocks proliferation 
rather than slowing it, and 
subsequently stimulates apoptosis. 
Leucine restriction as well as 
LY294002 treatment did result in cell 
size shrinking but also increased 
apoptosis rates above that of control cells, implying that there may be a second signaling 
mechanism being altered (c-myc in leucine depletion). Of great importance, smaller cells 
resulting from a 24hr rapamycin treatment were resistant to drugs inducing apoptosis 
including staurosporine (0.3uM for 6 hrs) as revealed from DNA fragmentation and 
annexin-V staining for cell surface phosphotidylserine detection, and caspase 8, 9  and 3 
cleavage. But is this phenomenon really due to cell size decreases or is it due to mTOR 
inhibition alone? Inhibition of S6K signaling was complete by 2 hours of rapamycin 
treatment, however at 4 hours there was no protection from apoptosis induction. On the 

























Figure 16: The mean surface area of Caco-2 cells was calculated 




completely repaired), apoptosis in response to anti-CD95 antibody is restored to wildtype 
levels. 
The SPCA orthologue, Pmr1p, has been implicated in TOR signaling in baker’s 
yeast. pmr1 mutant strains were less sensitive to rapamycin inhibition implying 
hyperactivity of TOR signaling in this background. Thus, the inhibition of TORC1 
signaling was mediated by Golgi manganese levels (Devasahayam et al. 2007). Although 
we did not detect any evidence that the SPCAs regulate EMT in Caco-2 cells, the 
serendipitous observation that cell size is reduced by shSPCA2 is compelling and merits 
further investigation. Given that TOR signaling has been implicated in cell size regulation, 
the effect of SPCA knockdown on mTOR signaling deserves consideration. In addition to 
the aberrant ER/Golgi structures identified by Okunade et al., an increase in the number of 
lipid droplets in all cell types examined was found. Perhaps this is evidence that autophagy 
is impaired in these cells (Singh et al. 2009). Indeed, mTOR signaling inhibits autophagy 
(Neufeld 2012) and perhaps these nonideal metabolic conditions restrict cell size. 
 
MATERIALS AND METHODS: 
TER Measurement: Caco-2 were seeded to transwell dishes 1.5e5 cells per well. TER 
measurements were recorded beginning at three days post plating and values were 
subtracted from those obtained from a sterile well. 
WGA and Phalloidin Staining: Caco-2 were allowed to differentiate for 14 days on a 
collagen coated coverslip. In order to stain for wheat germ agglutinin, cells were labeled 
with 1:100 TRITC-WGA in DMEM for 5 minutes before washing and fixing cells as 
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described under immunofluorescence staining. To stain for phalloidin, cells were stained 
with 1:100 phalloidin-FITC for 30 minutes in PBS with 1% BSA. 
Immunofluorescence Staining: Immunofluorescence staining protocols were modified 
from Araki et al. 1993. In brief, cells were washed twice in PBS before performing a pre-
extraction in 0.025% saponin in PHEM buffer (60mM PIPES, 25mM HEPES, 10mM 
EGTA, and 2mM MgCl2 at pH 6.8) for two minutes. Cells were washed two times in 
saponin/PHEM buffer containing 8% sucrose. For fixation, cells were incubated in 4% 
paraformaldehyde in PBS plus 8% sucrose for 30 minutes in the dark. After washing 
blocking and staining procedures were continued in PBS plus 1% BSA with 0.025% 
saponin. DAKO Antifade Mounting Solution was used for final mounting of coverslips. 
Mean cell surface area: Caco-2 were differentiated for 14 days after seeding transduced 
and selected cells. Cells were seeded at a concentration of 1.5e5 cells/ml. After 14 days, 
cells were stained for E-cadherin and imaged using epifluorescence. The mean area per cell 
was calculated by dividing the frame area in pixels^2 by the net total of Caco-2 cells within 




SPCA2 AND TRPV6 INTERACT IN AN OVEREXPRESSION MODEL 
We became interested in the possibility that SPCA2 may be involved in calcium 
absorption through the digestive tract. The duodenum is responsible for absorbing the vast 
majority of calcium via the TRPV6 channel, which is said to be constitutively active. 
However, as mentioned above, the duodenum can exhibit increased calcium absorption in 
response to vitamin D even in the TRPV6 knockout (reviewed in Centeno et al. 2009, Benn 
et al. 2008). The Golgi apparatus is involved in calcium absorption in enterocytes and is 
vitamin D-responsive (Freedman et al 1977). Additionally, calcium transport in Golgi-
derived vesicles from rat intestine was increased if rats were treated with vitamin D3 prior 
to extraction. This transport was ATP dependent. (Arab and Ghishan 1989). Retinoid X 
receptors (RXRs) can dimerize with vitamin D receptors (VDR) to form a transcriptional 
activating unit that acts on vitamin D response elements. Nearly 500bp upstream of the 
SPCA2 gene a RXRA/VDR binding site can be found, thus it is plausible that isoform 2 is 




Figure 17: Predicted promoter elements for human SPCA2. SwissRegulon: a database of genome-wide annotations of 
regulatory sites. Mikhail Pachkov, Ionas Erb, Nacho Molina and Erik van Nimwegen. Nucleic Acids Research, 2007, Vol. 











We hypothesized that SPCA2 may be 
responsible for this effect via store-
independent calcium entry (SICE). First, we 
tested whether or not SPCA2 transcript was 
induced in response to vitamin D3 (100nM) 
for 24 hours. Cycle threshold values were 
normalized to GAPDH. Although TRPV6 
transcript was induced over five-fold, we did 
not detect an increase in the transcript levels 
of either SPCA1 or SPCA2. Therefore 
SPCA1 and 2 are not transcriptionally regulated by vitamin D3. Fold induction of hTRPV6 
is in accord with previously published studies (Fleet et al. 2002) showing a 3-fold induction 
upon vitamin D3 treatment of Caco-2 bbe1. 
 We next sought to test whether or not SPCA2 may be involved in a calcium entry 
mechanism that involves the TRPV6 channel. Like Orai1, TRPV6 has been implicated in 
SOCE for numerous reasons. First, TRPV6 is highly selective for calcium transport. 
TRPV6 also shares some biochemical features of the CRAC channel (Krebs and Michalak, 
2007). Additionally, preliminary data from the lab shows that SPCA2 can interact with a 
number of TRP channels. To this end, we hypothesized that SPCA2 interacts with TRPV6 
and that this interaction regulates calcium entry through the TRPV6 channel, thus 
implicating SPCA2 in transepithelial calcium transport in the intestinal epithelium. 
 In HEK293 cells, epitope-tagged SPCA and TRPV6 were co-immunoprecipitated 
with antibody against HA or GFP. First SPCA2 appeared to bind TRPV6 specifically 
Figure 18: Fold upregulation of SPCA2 and TRPV6 in 






















because SPCA1 was undetectable in the pull down lane. In retrospect, this observation may 
be due to the reduced expression of SPCA1 compared to SPCA2 via ectopic plasmid DNA. 
Second, we attempted to identify the interacting domain(s) of SPCA2 by mutational 
analysis (Feng et al. 2010). In these constructs, SPCA2 N or C termini (or both) were 
swapped with the sequences for SPCA1. Pulldown with antibody against HA may have 
been convoluted by the nonspecific binding of YFP-TRPV6 (Mike Caterina, personal 
communication). To control for this, we pulled down with antibody against GFP in order 
to detect HA-SPCA binding. All expressed HA-SPCAs bound to YFP-TRPV6, including 
SPCA2 constructs in which N or C-termini involved in Orai1 interaction have been 
mutagenized to carry SPCA1 sequences. Thus we conclude that SPCA interactions with 




Figure 19: Coimmunoprecipitation of HA-SPCA1 or HA-SPCA2 with YFP-TRPV6 pulled down with antibody against HA 
(upper left panel). A detailed diagram of the expression constructs used in the lower panels is included. In order to 
determine the regions conferring binding specificity to SPCA2 we performed coimmunoprecipitation with antibody 
against either HA or GFP (bottom left and right panels, respectively.  
Finally, we wanted to address the possibility that SPCA2 binding to TRPV6 has a 
regulatory role on channel’s activity. In HEK293 cells, the strain used mattered in the effect 
of SPCA2-induced nuclear translocation of NFAT. We chose to work with HEK293A 
which seemed to have a dose-response to the amount of HA-SPCA2 transfected into the 
cells. YFP-TRPV6 induced NFAT translocation in approximately 80% of cells. Addition 
of HA-SPCA2 did not induce nuclear translocation above that of TRPV6 alone. One 
possible explanation for this finding is that the upper limit of this assay has been reached. 
Indeed, conditions involving transient transfection that induced maximal nuclear 




Figure 20: NFAT translocation studies in two independent HEK293 strains (left). SPCA2 failed to illicit NFAT-translocation 
above that of TRPV6 alone when combined with the apical calcium channel (right). 
 
Figure 21: SPCA2 and TRPV6 are inducible in a TREx system. 
 In conclusion, we were unable to find evidence that SPCA2 is regulated 
transcriptionally by vitamin D3 and while both SPCA1 and SPCA2 can interact with 
TRPV6, no upregulation of NFAT translocation was observed. Given these findings, it is 
difficult to support the hypothesis that SPCA2 is eliciting calcium entry in HEK293 cells 




 Although colorectal cancer is a disease stemming from mutations of cancer stem 
cells, numerous environmental factors contribute to the probability of cancer development. 
Indeed, microorganisms have been associated with the development of colorectal cancer 
and can for the first time be identified by genomics. With the emergence of high-throughput 
sequencing techniques, an interest has risen in the field of the microbiome, or the entirety 
of microorganisms living with the human body.  
 Over three million genes belonging to greater than 1,000 microorganisms currently 
comprise the human intestinal microbiota. Among prokaryotes, the three most prominent 
taxa (Firmicutes, Actinobacteria and Bacteroidetes) account for over 80% of the sequences 
attained (reviewed in de Vos and de Vos, 2012). Bacteria contributing to colorectal 
mutagenesis are the unusual but eminent. Enterotoxigenic Bacteroides fragilis (ETBF) is 
a gram negative causing diarrhea and colitis in the host. The secreted toxin, B. fragilis toxin 
(BTF), cleaves E-cadherin in colon enterocytes. E-cadherin suppresses the activity of the 
oncogene, B-catenin, which is constitutively active in nearly all colon cancers. Thus, loss 
of E-cadherin results in hyperproliferation of existing colon cancers. (Housseau and Sears, 
2010). Similarly, Fusobacterium nucleatum adhesin, FadH, binds and inactivates E-
cadherin thus promoting B-catenin activation (reviewed in Gagliani et al. 2014). 
 The microbiota is a system in delicate balance, modulated by factors including diet, 
host health, and immune responses. A proinflammatory environment not only alters the 
microbial milieu but it results in elevated ROS thus damaging enterocytes. Consequently, 
overgrowth of a species triggering immune responses can result in colorectal cancer as well 
(Gagliani et al. 2014). 
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 Deep sequencing has picked up only a few genes belonging to fungi of the intestinal 
microbiome. Below, we examined the opportunistic pathogen, Candida albicans, which 
resides in the intestine of healthy individuals. Many factors are involved in the regulation 
of the C. albicans population size including probiotic Lactobacillus plantarum LPK (Payne 
et al. 2003). Although C. albicans has not been implicated in colon cancer development, it 
has been recognized that oral growths are associated with oral squamous cell carcinoma 
(Bakri et al. 2010). Candida do retain the propensity to establish a systemic infection in 
immunocompromised individuals. Below, we examine the relationship between C. 






CANDIDA ALBICANS AS AN OPPORTUNISTIC PATHOGEN 
An opportunistic pathogen is an organism that has the ability to cause disease when 
conditions are favorable. Candida albicans resides as a commensal in our mouths, 
digestive tracts, and genitalia as a commensal organism. Only certain environmental cues 
allow C. albicans to establish an infection or disseminate to other sites (Calderone and 
Fonzi, 2001). 
Crucial to the progression from commensal to pathogen is dimorphic switching. 
Factors that may initiate a dimorphic transition includes serum or GlcNAc, proline, 
increase in temperature to 37°C. Dimorphic switching is frequently associated with 
virulence. In a study by Susan Noble’s group, 674 genes were mutagenized in Candida 
albicans and examined for bud-hyphae transition defects. Of 115 virulence-attenuated 
strains roughly half underwent normal dimorphic switching in the lab. 
Certain virulence factors are involved in C. albicans dimorphism. Key in the 
process of germination are adhesins, a collection of proteins that allow yeast to bind host 
mucosa through interacting with a variety of partners including fibronectin, laminin, 
collagen I and IV. Certain transcription factors must also respond to changing 
environments and cue morphogenesis. Efg1p, Tup1p, and Rim101p are C. albicans 
transcription factors whose mutation results in pseudohyphae, constitutive hyphae or 
reduced hyphae, respectively. Secreted aspartyl proteases and phospholipases contribute to 
virulence by causing tissue damage (Calderone and Fonzi 2001). 
 In the gut, barriers such as tight junctions, the mucosa and secreted small 
antibacterial peptides are the first line of defense against the intestinal microbiota. Next, 
macrophages and neutrophils comprise the innate immune response and can clear microbes 
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by phagocytosis. Innate immune cells have the added responsibility to release pathogen 
antigens in order to mount an adaptive immune response. 
 In a murine model it was found that neutropenia was a key predisposing factor in 
septic candidiasis emerging from the digestive tract (Koh et al. 2008). Chemical damage 
to the intestinal epithelium increased the efficiency of delivery of C. albicans to the 
bloodstream yet neutropenia was essential for infection establishment. This closely 
mimicks epidemiological data in which primarily immunocompromised individuals are 
affected by this pathogen. Thus, numerous factors play a role in the overall infectivity of 





ESSENTIAL ROLE FOR VACUOLAR ACIDIFICATION IN CANDIDA ALBICANS 
VIRULENCE 
The entirety of this chapter has appeared in the Journal of Biological Chemistry as a 
manuscript accepted for publication in 2013: 
Patenaude C., Zhang Y., Cormack B., Kohler J., Rao R. (2013) Essential Role for 
Vacuolar Acidification in Candida albicans. J Biol Chem. 288(36) 26256-64. 
Abstract 
Fungal infections are on the rise, with mortality above 30% in patients with septic 
Candida infections. Mutants lacking V-ATPase activity are avirulent and fail to acidify 
endomembrane compartments, exhibiting pleiotropic defects in secretory, endosomal, and 
vacuolar pathways. However, the individual contribution of organellar acidification to 
virulence and its associated traits is not known. To dissect their separate roles in Candida 
albicans pathogenicity we generated knock-out strains for the 
V0 subunit a genes VPH1 and STV1, which target the vacuole and secretory pathway, 
respectively. While the two subunits were redundant in many vma phenotypes, such as 
alkaline pH sensitivity, calcium homeostasis, respiratory defects, and cell wall integrity, 
we observed a unique contribution of VPH1. Specifically, vph1Δ was defective in 
acidification of the vacuole and its dependent functions, such as metal ion sequestration as 
evidenced by hypersensitivity to Zn2+ toxicity, whereas stv1Δ resembled wild type. In 
growth conditions that elicit morphogenic switching, vph1Δ was defective in forming 
hyphae whereas stv1Δ was normal or only modestly impaired. Host cell interactions were 
evaluated in vitro using the Caco-2 model of intestinal epithelial cells, and murine 
macrophages. Like wild type, stv1Δ was able to inflict cellular damage in Caco-2 and 
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macrophage cells, as assayed by LDH release, and escape by filamentation. In 
contrast, vph1Δ resembled a vma7Δ mutant, with significant attenuation in host cell 
damage. Finally, we show that VPH1 is required for fungal virulence in a murine model of 
systemic infection. Our results suggest that vacuolar acidification has an essential function 
in the ability of C. albicans to form hyphae and establish infection. 
Introduction 
Infectious microbes have evolved a surprising array of strategies to identify and 
infect host cells for optimal pathogen survival and propagation. Critical to the process of 
microbial pathogenesis is the manipulation and response to pH. For example, Salmonella 
typhimurium evades host defense mechanisms by synchronizing the construction of the 
type III secretion system with macrophage lysosomal acidification (Buezon et al., 1999). 
The facultative intracellular fungal pathogenHistoplasma capsulatum survives and 
replicates within macrophages by inhibiting phagolysosomal fusion and regulating 
phagosomal pH to acquire nutrients, including iron (Hilty et al., 2008). In pathogenic 
yeasts, such as Candida albicans, pH has been implicated in proliferation, dimorphic 
switching between budding and hyphal forms, and virulence (Zhang and Rao, 2010). C. 
albicans is also a successful commensal, surviving in host niches with ambient pH ranging 
from highly acidic (pH <2) to alkaline (pH >10) (De Barnardis et al., 1998; Vylkova et al., 
2011). 
Central to each of these processes is the V-ATPase, a multisubunit, evolutionarily 
conserved proton pump that maintains pH gradients across the endomembranes of the 
secretory, vacuolar, and endocytic pathways in the fungal cell. The role of the V-ATPase 
in fungal physiology is far-reaching, impacting diverse cellular pathways ranging from 
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protein processing and degradation, endocytic trafficking, pH-driven exocytosis, to the 
transport and sequestration of metabolites, ions, and toxic drugs (Kane, 2007). Impairment 
of V-ATPase activity can cripple many processes important for infection: secretion of 
virulence factors, filamentation, and host tissue invasion, biofilm formation, countering 
host immunity, and tolerance to antifungal drugs (Zhang and Rao, 2010; Zhang and Rao, 
2012). Not surprisingly, C. albicans vma7 mutants, with complete loss of V-ATPase 
activity, are avirulent (Poltermann et al., 2005). 
The pleiotropic effects of vma mutants lacking all V-ATPase activity, do not offer 
a means to dissect the individual contribution of organellar acidification to virulence and 
associated traits. In the budding yeast Saccharomyces cerevisiae, only the V-ATPase 
subunit a is expressed as two organelle-specific isoforms: Stv1p and Vph1p, that localize 
to the Golgi and secretory pathway, or to the vacuolar membranes, respectively. Extensive 
studies in this non-pathogenic model yeast have clarified the individual roles of these 
distinct secretory and vacuolar V-ATPase isoforms in the development of pH gradients 
across endomembrane compartments. The ∼100 kDa a subunit is an integral part of the 
membrane embedded Vo domain where it forms two hemichannels constituting the proton 
conduction pathway and provides the essential positively charged counterion to facilitate 
dissociation of bound protons. Stv1p containing V-ATPase complexes differ from Vph1p 
containing enzymes in having a lower coupling efficiency of the ATP hydrolytic activity 
with proton transport, and lower assembly efficiency with the cytoplasmic V1 ATPase 
domain (Kawasaki-Nishi et al., 2001). Consequently, invph1-null mutants, Stv1p-
containing V-ATPase is unable to efficiently acidify the vacuolar compartment (Manolson 
et al., 1992; Perzov et al., 2002). In contrast, Vph1p-containing V-ATPase complexes 
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appear to compensate for loss of the secretory isoform in stv1-null mutants, presumably in 
transit to the vacuolar membrane (Manolson et al., 1994). 
The unique role of the Vph1p isoform offers an approach to specifically evaluate 
the role of vacuolar acidification in the development of virulence-associated traits in C. 
albicans. S. cerevisiae vph1-null mutants display only a partial vmaphenotype, with no loss 
of function reported in a number of cellular pathways where Vph1p has a redundant role 
with Stv1p (Manolson et al., 1994). This functional redundancy offers the potential to mask 
the contribution of these pathways to virulence in C. albicans. With these goals in mind, 
we identified the two subunit a orthologs in C. albicans and confirmed their subcellular 
localization to the secretory and vacuolar compartments. We describe distinct phenotypes 
of C. albicans stv1 and vph1 null mutants and establish an essential role for vacuolar 
acidification in virulence. These novel findings extend and clarify the in vitro findings of 
Raines et al., who recently demonstrated overlapping functions of Stv1p and Vph1p in C. 
albicans. Given the urgent need to expand the arsenal of antifungal drugs against the 
growing threat of candidiasis and other fungal infections, our findings validate the 
importance of the V-ATPase, and specifically, vacuolar acidification as a drug target 
(Zhang and Rao, 2012, Johnson et al., 2010). 
EXPERIMENTAL PROCEDURES 
Animal Studies 
All animal work was conducted at The Johns Hopkins University according to 
guidelines established by the private Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) International. The Johns Hopkins University's 
Animal Care and Use Committee approved all animal procedures conducted under the 
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protocol entitled, “Isolation of Virulence Genes in Candida” (protocol number 
MO10M234; approval renewed on 11/20/2012). 
Yeast Strains and Plasmids 
SN152 (arg4Δ/arg4Δ, leu2Δ/leu2Δ, his1Δ/his1Δ, URA3/ura3Δ) was generously 
donated by Susan Noble (UCSF) (Noble and Johnson, 2005). This background was used 
to create homozygous null mutants in STV1 and VPH1, as well as STV1-GFP and VPH1-
GFPfusion strains. An isogenic pair of wild type and homozygous vma7-null mutant was 
generously donated by Raimund Eck (Hans Knöll Institute, Germany) (Poltermann et al., 
2005). pGEM-HIS plasmids containing C. albicans STV1 and VPH1 were kindly donated 
by Karlett Parra (University of New Mexico) (Raines et al., 2013). 
Generation of GFP-tagged Yeast Strains 
STV1-GFP and VPH1-GFP strains were created by transforming SN152 with their 
respective fusion cassettes. First, a synthetic GFP gene optimized for expression in C. 
albicans was inserted into pJK1027 downstream of the ClonNat cassette to generate 
plasmid pZR15.5. pJK1027 is an integration vector carrying nourseothricin resistance and 
regions homologous to the actin promoter. pJK1027 was constructed by excising a cassette 
containing the CaNAT1 gene flanked by the Ashbya gossypii TEF1 transcriptional 
promoter and terminator from pJK795 (Shen et al., 2005) with EcoRV and KpnI. The 
fragment was blunted with Klenow and ligated into pAU34 (Uhl and Johnson, 2001), 
which had been digested with NdeI and treated with Klenow. Next, the GFP-ClonNat 
fusion fragment was amplified from pZR15.5 with a 45 bp linker sequence attached 
upstream of the GFP sequence. Then the STV1open reading frame (ORF)3 (stop codon 
removed) plus ∼500 bp upstream (5′-UTR-STV1) and ∼500 bp immediately downstream 
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of the ORF (3′-UTR) were amplified separately. Next the three PCR amplicons (5′-UTR-
STV1, linker-GFP-ClonNat, and 3′-UTR) were fused together by a one-step PCR. Finally 
this fusion PCR cassette was transformed to SN152 to replace one copy of the wild 
type STV1gene and generate the STV1-GFP strain YZR226. The VPH1-GFP strain was 
generated similarly. 
Generation of Null Mutants 
STV1 and VPH1 null strains were generated as described previously (Noble et al., 
2010) and confirmed by PCR amplification. Briefly, gene disruption cassettes containing 
either Candida dubliniensis HIS1 or Candida maltosa LEU2 flanked by ∼350 upstream 
and downstream of the STV1 and VPH1 genes were constructed by fusion PCR. 
Heterozygous deletion strains were constructed by transformation of SN152 with a HIS1-
marked gene disruption cassette; His+ transformants were screened by colony PCR for the 
presence of expected 5′ and 3′ junctions of the integrated DNA. Homozygous gene 
disruption strains were constructed by transformation of the heterozygous knock-out strain 
with a LEU2-marked gene disruption cassette; His+ Leu+ transformants were screened for 
expected 5′ and 3′ junctions of the second disrupted allele, absence of the original target 
ORF, and the presence of CdHIS1 and CmLEU2 ORF. The following null strains were 
generated: YZR218 
(arg4Δ/arg4Δ, leu2Δ/leu2Δ, his1Δ/his1Δ, URA3/ura3Δ,stv1Δ::Leu2/stv1Δ::His1) and 
YZR219 
(arg4Δ/arg4Δ, leu2Δ/leu2Δ, his1Δ/his1Δ,URA3/ura3Δ, vph1Δ::Leu2/vph1Δ::His1). 
Generation of Reintegrants 
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VPH1 ORF and flanking regions were cloned into pJK1027, an integration vector 
carrying nourseothricin resistance and regions homologous to the actin promoter. The 
plasmids were linearized by restriction digestion with BsrI and subsequently transformed 
into the appropriate knock-out strains. Transformants were selected on YPD supplemented 
with nourseothricin (100 μg/ml). Confirmation of reintegration was by PCR amplification 
and by showing a reversal of zinc hypersensitivity. 
Yeast Growth 
C. albicans strains were maintained on YPD plates unless specified otherwise. 
Sensitivity to Zn2+ was monitored in synthetic complete (SC) or YPD medium 
supplemented with ZnCl2 to 0.5 mM. Sensitivity to acidic pH was conducted in SC medium 
buffered with 50 μM sodium citrate and adjusted to pH 2.5. Sensitivity to alkaline pH was 
conducted in SC medium, which was buffered with 50 mM MOPS and adjusted to pH 8. 
Respiration deficiency was assessed in YPEG which contained 1% Bacto-yeast extract, 2% 
Bacto-peptone, 3% glycerol, and 2% ethanol. Calcium homeostasis deficiency was 
assessed in SC medium at pH 6 supplemented with FK506 to 2 μg/ml. Sensitivity to 
calcofluor white was assessed on YPD supplemented with calcofluor white to 20 μg/ml. 
pH Measurements 
Vacuolar pH was measured with BCECF-AM (Molecular Probes, Eugene, OR), a 
pH-sensitive fluorophore that accumulates in the yeast vacuole (Zhang et al., 2010; Brett 
et al., 2005). Yeast strains were grown to mid-logarithmic phase in YPD medium. Cells 
were collected by centrifugation and incubated in SC containing 50 μM BCECF-AM for 
25 min then washed twice before being resuspended in SC to OD 2 and transferred to a 96-
well plate. Fluorescence emission at 520 nm was measured with dual excitation at 485 nm 
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and 450 nm in a Fluostar Optima plate reader. All measurements were taken from samples 
in triplicate. Vacuolar pH was calculated using a calibration curve covering pH from 4 to 
8.5 as described (Brett et al., 2005). 
Hyphal Development 
Late exponential-phase cultures grown at 30 °C were diluted 10-fold into fresh 
YPD supplemented with 10% (w/v) FCS at 37 °C as described previously (Poltermann et 
al., 2005) to induce hyphal growth in liquid medium. Hyphal growth in solid media was 
induced on Spider plates as described previously (Poltermann et al., 2005). 
Cell Adhesion and Damage 
C. albicans were grown for 6 h from a starter culture, sonicated in a water bath to 
disperse clumps, and 5000 cells were applied to a monolayer of Caco-2 cells grown in a 
35-mm dish for 10 days. After 30 min, culture supernatant was collected, diluted, and 
plated to YPD to estimate the number of non-adherent yeast cells. The Caco-2 monolayer 
was washed briefly five times with PBS and then cells were scraped in 1 ml PBS and the 
lysate was plated on YPD to calculate the number of adherent yeast cells. Data represented 
shows the number of adherent cells compared with the total number of viable cells used. 
Data shown are an average of three experiments with error bars displaying the standard 
error of the mean. p values were calculated using the Student's t test. 
J774A.1 macrophages were grown as confluent monolayer in high glucose DMEM 
without sodium pyruvate supplemented with 10% FBS in 24-well plates. They were 
infected with the indicated C. albicans strains at multiplicity of infection of 5. The 
following morning, cellular medium was aspirated and fresh medium was applied to the 
monolayer. After 4 h, medium was collected, and lactate dehydrogenase activity was 
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measured as per manufacturer's protocol (Promega CytoTox 96 Nonradioactive 
Cytotoxicity Assay). 
Systemic Infection 
Virulence assays were performed as modified from Noble and Johnson. In short, C. 
albicans were grown overnight at 30 °C and then used to inoculate at second culture (by a 
1:30 dilution). After 5 h, optical densities were determined. Cells were pelleted at 2000 
rpm for 5 min and then washed once with normal saline and serially diluted to achieve 8 × 
106 cells/ml for tail vein injections. 0.1 ml was injected into each of Balb/c female mice 
that were 8–10 weeks old. We injected 10 mice per strain and monitored death over 25 
days. Mice that were moribund, showing weight loss, hunched posture, failure to groom, 
and/or motor deficits, were euthanized. Survival curves were analyzed using the log rank 
test. 
RESULTS 
Localization of Vo Subunit a Isoforms to Vesicular (Stv1p) and Vacuolar (Vph1p) 
Compartments in C. albicans 
Two C. albicans ORFs have been annotated as V-ATPase subunit a 
STV1 and VPH1(www.candidagenome.org). These two paralogs have 48.2% amino acid 
identity with one another. The putative CaVph1p (orf19.6863) and CaStv1p (orf19.1190) 
proteins share identities of 74.9 and 73.5% to their respective Saccharomycesorthologs. 
Neither ORF contains the N-terminal WKY motif that has been identified as targeting 
sequence for secretory pathway localization inSaccharomyces ortholog Stv1p (Finnigan et 
al., 2012), although putative CaStv1p does contain a WKY motif within a loop region. 
FXFXD motifs at positions 221 and 755 were previously described as the putative 
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localization sequences for Golgi retention of ScStv1p (Manolson et al., 1994). Putative 
CaStv1p also contains a FXFXD motif (822–826, FNFGD) whereas CaVph1p does not. 
To confirm these in silico predictions, we tagged each ORF with C-terminal GFP at the 
chromosomal locus in wild type C. albicansstrain SN152. Consistent with bioinformatics 
data, live fluorescence imaging of transformed yeast showed punctate labeling for CaStv1-
GFP (Fig. 1B), reminiscent of secretory pathway staining of Golgi, endosomes, and 
prevacuolar compartments in S. cerevisiae. CaVph1-GFP localized to the vacuolar 
membrane marked by the vacuolar dye FM4–64 in live cells (Fig. 1C), similar to S. 
cerevisiaeVph1-GFP (Manolson et al., 1994). 
Redundant Roles for Stv1p and Vph1p Revealed by Lack of Some vma Phenotypes 
As expected for its diverse role in pH and ion homeostasis, loss of V-ATPase 
function is accompanied by pleiotropic defects that include the growth sensitivity to acid 
or alkaline stress, calcium signaling, cell wall integrity, and cell respiration. To assess the 
functional redundancy of a subunit isoforms Stv1p and Vph1p to these processes, we 
generated homozygous null mutant strains stv1Δ/stv1Δ and vph1Δ/vph1Δ isogenic to C. 
albicans SN152. Vma7p is an essential subunit of the V-ATPase that drives the rotary 
catalytic mechanism (Nelson et al., 1994). Therefore, we used the homozygous null 
mutant vma7Δ/vma7Δ along with its isogenic control, to elicit the vma phenotype 
(Poltermann et al., 2005). While all strains grew well in YPD medium buffered to pH 4.0, 
the homozygous vma7 mutant showed characteristic growth sensitivity at extremes of acid 
(pH 2.5) and alkaline (pH 8.0) media as has been reported for S. cerevisiae vma mutants. 
Mutants lacking Stv1p or Vph1p, however, showed normal or near normal growth (Fig. 
2A). Calcium homeostasis defects in vma mutants are exacerbated by loss of calcineurin 
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signaling, resulting in synthetic lethal phenotype (Hemenway et al., 1995; Tanida et al., 
1995). Addition of the calcineurin inhibitor, FK506, under conditions of mild alkaline 
stress (pH 6.0) resulted in nearly complete inhibition of growth in the vma7 mutant, 
whereas neither stv1 nor vph1mutants were affected (Fig. 2B). Furthermore, vma mutants 
show signs of oxidative stress and defects in cellular respiration (Manolson et al., 
1994, Milgrom et al. 2007). We show that C. albicans vma7 mutant is unable to grow on 
glycerol as a non-fermentable carbon source (YPEG, Fig. 2C). However, deletion of 
neither of the two Vo subunit aisoforms revealed any growth sensitivity on this medium 
(Fig. 2C). Similarly, slow growth of vma7 mutant on YPD plates was further impaired by 
calcofluor white, an agent previously shown to cause cell wall stress, but this was not 
observed invph1- or stv1-null mutants (Fig. 2D). We conclude that the two isoforms of 
subunit a play redundant roles in a wide range of functions attributed to the V-ATPase. 
VPH1 Is Essential for Vacuolar Acidification and Function 
The acidic pH established by the H+ pumping activity of the V-ATPase is central 
to the function of the vacuole or lysosome in eukaryotic cells. We used the ratiometric pH 
indicator BCECF to measure the pH of the yeast vacuole. The acetoxymethyl form of 
BCECF is taken into the cell and de-esterified in the yeast vacuole, where it becomes 
trapped (Fig. 3A, inset) allowing quantitative estimation of pHv in live yeast. As expected, 
vacuolar pH in wild type yeast was acidic, ranging from pH 5.12 ± 0.088 in SN152 and 
5.54 ± 0.053 for CNC44. Loss of Vma7p resulted in significant vacuolar alkalinization by 
1.43 pH units. Similarly, pHv was increased by 1.44 pH units in the vph1 null mutant but 
did not alter significantly in stv1 mutant (pHv 5.5). This confirms extensive studies in S. 
cerevisiae showing isoform specificity of subunit a in vacuolar acidification. We conclude 
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that, as in S. cerevisiae, C. albicans Vph1p is required for robust vacuolar acidification, 
and that Stv1p is not capable of compensating for loss of Vph1p. 
The acidic vacuole is the major site of ion and metabolite sequestration, driven by 
the H+ gradient established by V-ATPase. Thus, the vma phenotype includes 
hypersensitivity to metal ions, including Co2+, Mn2+, Cu2+, Ni2+, and Zn2+ (Poltermann et 
al., 2005). We show increased sensitivity to elevations in extracellular zinc 
in vph1 and vma7null strains, relative to their isogenic controls (Fig. 3B), consistent with 
the absence of vacuolar acidification. Loss of Stv1p did not alter Zn2+ sensitivity, similar 
to findings in S. cerevisiae (Finnigan et al., 2012). 
Isoform-specific Differences in the Role of Vo Subunit a in Hyphal Development 
The vacuole is critical in germ tube formation and for invasive hyphal growth in C. 
albicans. Sub-apical vacuoles have been shown to rapidly fuse and enlarge, crowding out 
the cytoplasm, which remains confined to the advancing apical tip of the hypha (Palmer, 
2011). The critical importance of cellular pH homeostasis in hyphal development was 
indicated by a nearly complete inability of vma7 mutants to generate filaments in liquid 
Spider medium, which has mannitol as sole carbon source (Fig. 4) (Poltermann et al., 
2005). However, the relative contribution of transmembrane pH gradients in the secretory 
and vacuolar compartments in hyphal formation is unclear. Interestingly, the stv1 mutant 
showed significant reduction of nearly 40% in filamentation, with larger reduction (85%) 
observed in the vph1-null strain (Fig. 4). Because hyphal formation is reduced but not 
completely abolished in the absence of either subunit a isoform, these results suggest that 
Stv1p and Vph1p both contribute to germ tube formation in liquid cultures, but can 
compensate, at least in part, for each other. 
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Hyphal formation can also be visualized at the peripheral margins of yeast colonies 
growing on solid medium. In solid Spider medium, we observed significant differences in 
hyphal outgrowth between vph1 and wild type, but not for stv1 mutant (Fig. 5A, top panel). 
These differences are evident at 25× magnification of the colony periphery (Fig. 5A, bottom 
panel) and suggest that Vph1p is important for hyphal formation on solid media whereas 
Stv1p is largely dispensable. To confirm this, we also examined hyphal formation on solid 
YPD medium supplemented with serum. Again, the vph1 mutant was defective in 
filamentation seen at the periphery of colonies, like the vma7-null strain (Fig. 
5B,top and bottom panels). Taken together, our observations point to a role for Vph1p and 
vacuolar acidification in hyphal formation. 
Host Cell Interaction Differs among V-ATPase Mutants 
The intestinal mucosal barrier plays a critical role in determining virulence of C. 
albicans (Schulze and Sonnenborn, 2009). To be retained on the intestinal surface, yeast 
cells must adhere to epithelial membranes. Therefore, we tested whether V-ATPase 
mutants were defective in adhesion to a polarized monolayer of Caco-2 epithelial cells. 
Late log phase C. albicans were applied to a polarized, differentiated epithelial monolayer 
and allowed to attach for 30 min. Subsequently, yeasts remaining in the supernatant were 
collected and plated to determine if any loss in viability occurred during incubation at pH 
7.4. After five washes, Caco-2 were scraped and resuspended in PBS for plating to YPD. 
Like vma7, the stv1 mutant had a modest although statistically significant reduction in 
adhesion, suggesting a potential role for V-ATPase in secretion of adhesion factors (Fig. 
6A). Adhesion of vph1mutants was not reduced to statistically significant levels. However, 
adherence does not appear to be a defining feature in the relative virulence of the strains 
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tested. Thus, host cell damage in stv1 mutants was indistinguishable from wild type, as 
monitored by release of lactate dehydrogenase from Caco-2 monolayers exposed to yeast 
cells for 16 h. In comparison, loss of Vph1p did reduce cellular damage to Caco-2 cells, 
although this was not as drastic as seen with vma7mutant strain, which has a complete loss 
of V-ATPase activity (Fig. 6B). 
In systemic infection by Candida, professional phagocytes, including 
macrophages, constitute the first line of host defense. Fungal cells are internalized into the 
phagosome, which matures into an acidic phagolysosome where hydrolytic enzymes like 
cathepsin B are activated. In response, environmental cues such as CO2 concentration and 
pH trigger filamentation by C. albicans, followed by piercing of the macrophage 
membrane and escape. Here, we evaluate the interaction of V-ATPase mutants with 
cultured murine macrophage-like cells, J774A.1 (McKenzie et al., 2010). Following an 
overnight incubation at a multiplicity of infection of 5, wild type strains SN152 and CNC44 
were able to filament robustly (Fig. 6C), and kill macrophage cells as evidenced by release 
of LDH (Fig. 6D). In contrast, vma7 mutants failed to form filaments and escape 
macrophages, and were unable to elicit LDH release above that of control, uninfected 
macrophages. We observed no requirement for Stv1p in filamentation and no deficit in the 
ability to cause host cell damage. However, both filament formation and LDH release from 
macrophages were significantly attenuated in vph1 mutants (Fig. 6, C andD). 
Vph1p Is Required for Virulence in a Murine Systemic Infection Model 
Previously, vma7 mutants lacking all V-ATPase activity were shown to be avirulent 
in a mouse model of system infection (Poltermann et al., 2005). The distinct contributions 
of Vph1p and Stv1p in vacuolar acidification provided a unique opportunity to distinguish 
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between the relative roles of vacuolar and secretory pathway acidification by the V-ATPase 
in virulence. We generated a reintegrant of VPH1 in the null strain that was verified by 
PCR amplification and complementation of the Zn2+-sensitive phenotype (Fig. 7, A and B). 
Freshly grown, viable cultures (8 × 105 cells) of each of homozygous 
null, VPH1 reintegrant and corresponding wild type strain SN152 strains were injected into 
the tail vein of 8–10 week old female Balb/c mice (n = 10 each) and survival was scored 
over 25 days (Fig. 7C). The reintegrant was not statistically different in virulence from 
wild type (p value 0.168, log rank test) (Noble and Johnson, 2005). The stv1-null mutant 
retained virulence and was also similar to wild type (p value 0.5), whereas the vph1-null 
strain failed to kill any of the mice over the course of the observed period (p value 1.7e-
09). 
DISCUSSION 
As a master regulator of intracellular pH, the fungal V-ATPase is critical for a 
diverse range of cellular functions including vacuole acidification, vesicular transport, and 
trafficking, pH-dependent growth, metal ion homeostasis, hyphal growth, and 
pathogenicity. Not surprisingly, complete loss of V-ATPase activity in the vma7 mutant 
of C. albicans leads to loss of virulence (Poltermann et al., 2005), although it is not clear 
which of these many functions is critical for virulence. Here, we have confirmed and 
extended the phenotypes of vma7 mutants. In addition to previously known defects in 
alkaline pH sensitivity, endocytosis defects, and metal ion sensitivity, we also demonstrate 
impaired ability to deal with acid stress, calcium homeostasis, growth in non-fermentable 
carbon sources, and cell wall stress. Thus, the pleiotropic phenotypes of vma mutants 
observed in the model yeast S. cerevisiae readily extend to the pathogenic yeast C. 
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albicans. Importantly, we provide new observations showing that C. albicans 
vma7 mutants fail to colonize Caco-2 intestinal epithelia and are efficiently eliminated by 
macrophages. Mucosal barrier damage as well as neutropenia are required for 
dissemination in a mouse model of GI to bloodstream transport (Dieterich et al., 2002; Koh 
et al., 2008). 
Unlike mammalian orthologs of V-ATPase, the fungal enzyme shows little isoform 
diversity of the structural subunits, with the exception of the Vo subunita encoded by the 
orthologous genes VPH1 and STV1 in both S. cerevisiae and C. albicans. The distinct 
functional properties and organellar distribution of V-ATPase complexes containing either 
Vph1p or Stv1p offer a unique approach to dissect the relative contributions of vacuolar 
and secretory pathway acidification to virulence and associated traits such as the 
morphogenic switch from budding cells to hyphae. Although a null mutant of Vph1p was 
previously examined in the fungal pathogen Cryptococcus neoformans and shown to be 
avirulent (Erickson et al., 2001), the absence of additional a subunit isoforms in this 
organism meant that the lone VPH1 isoform was essential for all V-ATPase functions. 
As a starting point for our analysis, we localized two C. albicans open reading 
frames to the vacuole and secretory pathway and evaluated their null phenotypes. We show 
that the vacuole-specific subunit a isoform, Vph1p, is required for vacuolar acidification 
and that this function cannot be adequately performed by the Stv1p isoform, consistent 
with similar observations in the non-pathogenic yeast S. cerevisiae. While this study was 
underway, Raines et al. also generated stv1 and vph1 null mutants to show that vacuolar 
alkalinization in C. albicans required Vph1p. Indeed, ATP hydrolysis and proton pumping 
rates were severely reduced in isolated vacuolar membranes from vph1 mutant, but were 
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normal in the stv1 mutant (Raines et al., 2013). Consistent with these observations, 
functions tightly linked to vacuolar acidification are disrupted in vph1 mutants. This 
includes tolerance to metal ion toxicity (this work) and delivery or retention of the 
membrane-bound dye FM4–64 to the vacuole (Raines et al., 2013). However, many other 
cellular phenotypes are largely unaffected in the vph1- and stv1-null mutants, due to the 
functional redundancy of the two isoforms. Thus, we demonstrate characteristic 
vma phenotypes that are readily observed in the vma7-null strain (loss of pH tolerance, 
calcium homeostasis, cell wall stress, and respiratory defects) but not by 
either vph1 or stv1 mutants. 
A significant and novel finding of our study is the isoform-specific requirement for 
Vph1p in virulence-associated traits of hyphal formation, host cell infectivity and damage 
measured against in vitro models of intestinal mucosal cells and macrophages. This specific 
requirement for Vph1p was confirmed by lack of virulence of vph1-null mutants in a 
murine systemic model of candidiasis. In contrast, stv1 mutants showed no loss of 
virulence. Thus, vacuolar acidification may be linked to virulence in fungal pathogens. 
Previously, we had demonstrated a link between pHv and C. albicans virulence in the mode 
of antifungal action of azole drugs (Zhang and Rao, 2010; Zhang et al., 2010). Loss of 
ergosterol from vacuolar membranes, either by mutations in the biosynthetic erg pathway, 
extraction with cyclodextrin, or by treatment with fluconazole inactivated V-ATPase, 
inhibited vacuolar acidification and cell growth. We showed that V-ATPase activity, 
vacuolar acidification, and cell growth were concomitantly restored upon feeding cells with 




Although Raines et al. did not investigate virulence of vph1 and stv1mutants, they 
found that loss of Vph1p resulted in deficits in hyphae formation in some media (M199) 
but not in others (Spider, YPD + 10% serum). The reason for the difference from our 
findings is unclear and may lie within strain variations or experimental protocols since 
a vma mutant was not included for comparison. Inducing media stimulate multiple 
signaling pathways leading to morphogenic switching, and liquid medium is a stronger 
inducer in many C. albicans mutant strains when compared with solid medium (Ernst, 
2000). It would be interesting to know if the vph1 mutant reported by Raines et al. retained 
virulence in an animal model. Further clarification could be derived from the hyphal 
phenotype of a vma mutant in the same background as their vph1 mutant. The role of Stv1p 
remains elusive given the absence of specific and strong vma phenotypes in both model 
and pathogenic yeasts. The unique role of Stv1p may be unmasked under specific 
conditions such as glucose starvation, known to cause preferential dissociation of Vph1p 
containing V-ATPase complexes (Kawasaki-Nishi et al., 2001). Indeed, we did observe a 
significant decrease in hyphal formation in the stv1 mutant grown in liquid Spider medium. 
Recently, Kane and coworkers used a Golgi-localized pH reporter to show that luminal pH 
becomes more acidic rather than alkaline upon loss of S. cerevisiae Stv1p (Tarsio et al., 
2011). This unexpected acidification was even more pronounced in vma mutants with 
complete loss of V-ATPase activity, suggesting compensatory changes in organellar pH 
homeostasis that remain poorly understood. 
Why is pHv important for fungal pathogenesis? We know that pH homeostasis is 
crucial for the ability to sense and adapt to pH changes in various host niches, generate or 
transduce morphogenetic signals for yeast to hyphal differentiation, and to maintain vital 
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secretory and endocytic pathways necessary for the secretion of virulence factors. V-
ATPase may be responsible for assisting in metabolic signaling events that trigger hyphal 
inducing genes, as suggested by Poltermann et al. who attributed differences in hyphal 
phenotype induced by Spider and serum media to unique contributions from MAPK or 
cAMP signaling pathways. It is known that the Rim/Pal proteins that are required for 
ambient pH signaling and alkaline pH response interact with ESCRT/Vacuolar Protein 
Sorting components Vps28 and Vps32 (Cornet et al., 2009). Deletion 
of VPS28 and VPS32 alters pHv (Brett et al., 2011), confers sensitivity to alkaline pH 
growth, and reduces virulence of C. albicans (Cornet et al., 2005), suggestive of a role for 
pHv in the Rim/Pal signaling pathway. Alternatively, V-ATPase may be necessary for tip 
growth to establish polarity and germ tube formation. This is supported by Neurospora 
crassa vma-1 mutants that exhibit a hyperfilamentation phenotype where the hyphae have 
increased branching and decreased persistence at polarity growth sites (Bowman et al., 
2000). Furthermore, there is consistent evidence that antifungal drugs that disrupt pHv also 
block hyphal formation. Thus, fluconazole blocks yeast-to-hyphal transition (Ha and 
White. 1999), and inhibits V-ATPase by depleting membranes of ergosterol, leading to 
alkalization of the vacuole (Zhang and Rao, 2010). Similarly, amiodarone exerts its 
antifungal effects by alkalinizing the vacuole, and at the same concentrations, also inhibits 
hyphal formation in C. albicans (Gamarra et al., 2010). The molecular mechanism 
underlying this phenotype was linked to transcriptional changes in genes regulating hyphal 
growth. Specifically, UME1, an inducer of hyphal development, showed no expression in 
the presence of amiodarone whereas the transcription factors TUP1, NRG1, and RFG1, that 
act as negative regulators of the morphogenetic switch, were all up-regulated in 
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amiodarone (Gamarra et al., 2010). Future work may identify specific contributions of 
pHv and distinguish between potential roles in pH sensing and response. 
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Figure 22: Multiple sequence alignment of STV1 and VPH1 genes (Candida albicans).  
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Figure 24: CaStv1p and CaVph1p localize to the secretory pathway and the vacuole, respectively. A. Diagram of 
budding yeast showing expected localization of VO a isoforms to the vacuole (Vph1p) and the Golgi and post-Golgi 
compartments (Stv1p), based on distribution of S. cerevisiae orthologs. Each C. albicans candidate ORF was cloned and 
C-terminal GFP-fusion constructs were expressed in WT cells. B. C. albicans ORF19.1190-GFP showed a punctate 
distribution consistent with secretory pathway morphology in yeasts. C. GFP-tagged ORF19.6863 localized to the 




Figure 25: Redundant roles of CaStv1p and CaVph1p. Phenotypes of C. albicans homozygous null mutants vph1 and 
stv1 were evaluated along with vma7 and their respective isogenic wild type strains. Cultures were incubated at 
30°C for 24 h and growth (Abs600) was expressed as percentage of the isogenic wild type control. A. Growth in 
response to acid (pH 2.5) and alkaline (pH 8) stress was similar to wild type in stv1 mutants, and mildly affected in 
vph1, compared to the vma7 strain, which showed little or no growth under extremes of pH. B. Ca2+ stress was 
elicited in medium buffered to pH 6 and supplemented with the calcineurin inhibitor FK506 (2 µg/ml). No growth 
sensitivity was observed in stv1 and vph1 strains, whereas vma7 showed pronounced inhibition of growth. C. 
Respiratory defect was monitored in YPEG medium containing non-fermentable carbon sources. Relative to the 
vma7, which showed significant respiration defects, stv1 and vph1 strains showed no loss of growth on non-
fermentable carbon sources. D. Response to cell wall stress was monitored on YPD plates supplemented with 
calcofluor white (20 µg/ml). No growth sensitivity to calcofluor white was observed in stv1 and vph1 strains, in 




Figure 26: Isoform-specific role for CaVph1p in vacuolar acidification and zinc tolerance. A. Vacuolar pH was 
measured using the ratiometric fluorescent dye BCECF-AM, which is de-esterified and accumulates inside the vacuoles 
of live yeast (inset) and pHv was calculated as described in Methods. Loss of Stv1p did not significantly alter 
acidification of the vacuole. In contrast, loss of Vph1 resulted in large (1.4 pH unit) vacuolar alkalization, similar to that 
seen in the vma7 mutant.  B. Vacuolar sequestration of toxic cations was assessed by evaluating Zn2+ toxicity in SC 
medium. Growth of homozygous null mutant strains is presented as a percentage of the isogenic wild type strain. Both 
vma7and vph1 strains were hypersensitive to elevated zinc concentrations (0.5 mM) whereas stv1 was similar to 




Figure 27:  Impairment of morphogenic switching in V-ATPase mutants. C. albicans was cultured in liquid spider 
medium for four hours and the number of cells showing hyphal development was determined by microscopic 
examination. In the wild type strain SN152, the majority of buds showed emergent hyphae (89%). Hyphal formation 
was decreased in stv1 to 55% and in vph1 to 15% of yeast cells. Nearly complete absence of morphogenic switching 




Figure 28:  Hyphal growth on solid medium is impaired in vph1 mutants. Colony morphology of V-ATPase mutants 
was monitored on A. solid Spider, and  B. solid YPD plates supplemented with FBS. In both conditions, peripheral 





Figure 29:  V-ATPase mutants have different effects on host cell infectivity in vitro. A. Infection from C. albicans is 
initiated by mucosal damage or invasion. V-ATPase mutant strains were tested for defects in host adhesion by 
applying 5000 yeast cells to Caco-2 monolayers for 30 minutes. The percentage of adherent cells was calculated 
relative to the total number of viable cells as described in Methods. During this time approximately 31% (SN152) or 
27% (CNC44) of WT cells adhered to the intestinal epithelial cells. The percentage of adhering cells in stv1 (23%) and 
vma7 (17%) strains was decreased, but the reduction was not statistically significant in vph1 mutants (27%). B. Host 
cell damage was evaluated by measuring release of the cytosolic enzyme LDH after overnight incubation of Caco-2 
monolayers with C. albicans. LDH release was significantly reduced in vph1 (to 60.9% of WT) and vma7 (to 11% of WT) 
but not stv1 mutants. Control cells were not exposed to yeast. C.  The ability of C. albicans to escape phagocytosis by 
macrophages was monitored in V-ATPase mutants and their wild type controls after incubation of yeast cells with 
J774A.1 cells as described in Methods. D. LDH release from J774A.1 cells after overnight incubation with C. albicans 
yeast was reduced in vph1 (41.1% of WT) and vma7 (9.4% of WT) mutants, consistent with defects in the ability to 




Figure 30  Vph1p is required for murine systemic infection. C. albicans blastoconidia (8x105), from the indicated 
strains, were injected into the tail vein of female Balb/c mice and virulence (defined by death or moribund phenotype) 
was monitored over a period of 25 days. Virulence of C. albicans was not decreased in stv1 relative to WT. In 
contrast, vph1 was avirulent. Virulence was restored by reintegration of VPH1 gene (vph1R).    
 
Figure 31: A) PCR analysis of genomic DNA showing deletion of VPH1 and STV1 in the null strains, and reintegration of 
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